Celsus Pharmaceuticals Philippines

They learned from studies that eighty percent (80%) of blindness is preventable if only medication was available. When the pioneers in the Philippine ophthalmic/otologic manufacturing and marketing industry finally met. with some of the country's authorities in ophthalmology and otolaryngology. The company was founded with the ultimate mission to p... roduce high quality, affordable and accessible eye and ear medicines to the general public. Now, on its twelve years of existence in the market, Celsus Pharmaceuticals is heading the way in the production of off-patent ophthalmic and otic medicines. Celsus has marked the trails, our quality has evolved as a benchmark among national ophthalmic/otic companies. In 2010, the Philippines Food and Drug Adminstration (FDA) has approved four (4) off-patent ophthalmic and otologic products, namely: 1. Ciprofloxacin 0.3% Eye Drops; 2. Ciprofloxacin 0.3% + Dexamethasone 0.1% Eye Drops; 3. Ciprofloxacin 0.3% Ear Drops; and 4. Ciprofloxacin 0.3% + 0.1% Dexamethasone Ear Drops.Read More